T cell-dependent regulation of eotaxin in antigen-induced pulmonary eosinophila

Journal of Experimental Medicine

Volumn 184, Issue 4, 1996, Pages 1461-1469

  MacLean, James A ^a   Ownbey, Robert ^a   Luster, Andrew D ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; EOTAXIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCLONAL ANTIBODY CD3; OVALBUMIN; RANTES;

ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; LOEFFLER PNEUMONIA; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES; ANTIGENS, CD3; BRONCHOALVEOLAR LAVAGE; CHEMOKINES, CC; CHEMOTACTIC FACTORS, EOSINOPHIL; CYTOKINES; HISTAMINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; MACROPHAGE INFLAMMATORY PROTEIN-1; MICE; MICE, INBRED BALB C; OVALBUMIN; PULMONARY EOSINOPHILIA; RANTES; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 0029961451     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.184.4.1461     Document Type: Article

References (43)

1. Dunhill, M.S. 1960. The pathology of asthma with special reference to changes in the bronchial mucosa. J. Clin. Pathol. 13:27-33.
2. Ann, J., and T. Lee. 1992. The pathobiology of asthma. Adv. Immunol. 51:323-382.
3. Azzawi, M., B. Bradley, P.K. Jeffery, A.J. Frew, A.J. Wardlaw, G. Knowles, B. Assoufi, J.V. Collins, S. Durham, and A.B. Kay. 1990. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am. Rev. Respir. Dis. 142:1407-1413.
4. Bousquet, J., P. Chanez, J. Lacoste, G. Barneon, N. Ghavanian, I. Enander, P. Venge, S. Ahlstedt, J. Simony-Lafontaine, and P. Godard. 1990. Eosinophilic inflammation in asthma. N. Engl. J. Med. 323:1033-1039.
5. Broide, D., G. Gleich, A. Cuomo, D. Coburn, E. Federman, L. Schwartz, and S. Wasserman. 1991. Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway. J. Allergy Clin. Immunol. 88:637-648.
6. Mossman, T.R., and R.L. Coffman. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-173.
7. Abu-Ghazaleh, R., H. Kita, and G.J. Gleich. 1992. Eosinophil activation and function in health and disease. Immunology Series. 57:137-167.
8. Thompson-Snipes, L., V. Dhar, M.W. Bond, T.R. Mosmann, K.W. Moore, and D.M. Rennick. 1991. Interleukin 10: a novel stimulatory factor for mast cells and their progenitors. J. Exp. Med. 173:507-510.
9. Geha, R.S. 1992. Regulation of IgE synthesis in humans. J. Allergy Clin. Immunol. 90:143-150.
10. Nakajima, H., I. Iwamoto, S. Tomoe, R. Matsumura, H. Tomioka, K. Takatsu, and S. Yoshido. 1992. CD4+ T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. Am. Rev. Respir. Dis. 146:374-377.
11. Renz, H., H.R. Smith, J.E. Henson, B.S. Ray, C.G. Irvin, and E.W. Gelfand. 1992. Aerosolized antigen exposure without adjuvant causes increased IgE production and increased airway responsiveness in the mouse. J. Allergy Clin. Immunol. 89:1127-1138.
12. + T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. Am. J. Respir. Cell Mol. Biol. 10:587-593.
13. Kung, T.T., H. Jones, G. Adams, S.P. Umland, W. Kreutner, R.W. Egan, R.W. Chapman, and A.S. Watnick. 1994. Characterization of a murine model of allergic pulmonary inflammation. Int. Arch. Allergy Immunol. 105:83-90.
14. Lukacs, N., R. Strieter, S. Chensue, and S. Kunkel. 1994. Interleukin-4-dependent pulmonary eosinophil infiltration in a murine model of asthma. Am. J. Respir. Cell Mol. Biol. 10: 526-532.
15. Garlisi, C., A. Falcone, T. Kung, D. Stelts, K. Pennline, A. Beavis, S. Smith, R. Egan, and S. Umland. 1995. T cells are necessary for Th2 cytokine production and eosinophil accumulation in airways of antigen-challenged allergic mice. Clin. Immunol. Immunopathol. 75:75-83.
16. + T lymphocytes and interleukin-5 in antigen-induced eosinophil recruitment into the site of cutaneous late-phase reaction in mice. J. Leukocyte Biol. 52: 572-578.
17. Foster, P., S. Hogan, A. Ramsay, K. Matthaei, and I. Young. 1996. Interleukin 5 deficiency abolishes eosinophilia, airways hypperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183:195-201.
18. Uchida, D.A., S.J. Ackerman, A.J. Coyle, G.L. Larsen, P.F. Weller, J. Freed, and C.G. Irving. 1993. The effect of human eosinophil granule major basic protein on airway responsiveness in the rat in vivo. A comparison with polycations. Am. Rev. Respir. Dis. 147:982-988.
19. Adelroth, E., L. Rosenhall, S.A. Johansson, M. Linden, and P. Venge. 1990. Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. The effects of antiasthmatic treatment with budesonide or terbutaline. Am. Rev. Respir. Dis. 142:91-99.
20. Burke, C., C.K. Power, A. Norris, A. Condez, B. Schmekel, and L.W. Poulter. 1992. Lung function and immunopathological changes after inhaled corticosteroid therapy in asthma. Eur. Respir. J. 5:73-79.
21. Djukanovic, R., J.W. Wilson, K.M. Britten, S.T. Wison, A.F. Walls, W.R. Roche, P.H. Howarth, and S.T. Holgate. 1992. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am. Rev. Respir. Dis. 145: 669-674.
22. Butcher, E.C. 1991. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell. 67: 1033-1036.
23. Springer, T.A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 76:301-314.
24. Baggiolini, M., B. Dewald, and M. Moser. 1994. Interleukin-8 and related chemotactic cytokines. Adv. Immunol. 55:97-179.
25. Jose, P.J., J.D. Griffiths, P.D. Collins, D.T. Walsh, R. Moqbel, N.F. Totty, O. Truong, J.J. Hsuan, and T.J. Williams. 1994. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J. Exp. Med. 179:881-887.
26. Rothenberg, M.E., A.D. Luster, and P. Leder. 1995. Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. Proc. Natl. Acad. Sci. USA. 92:8960-8964.
27. Garcia-Zepeda, E., M. Rothenberg, R. Ownbey, J. Celestin, P. Leder, and A. Luster. 1996. Human eotaxin is an eosinophil selective chemoattractant that provides a new mechanism to explain tissue eosinophilia. Nature Medicine. 2:449-456.
28. Ponath, P., S. Qin, D. Ringler, I. Clark-Lewis, J. Wang, N. Kassam, H. Smith, X. Shi, J.-A. Gonzalo, W. Newman, et al. 1996. Cloning of the human eosinophil chemoattractant, eotaxin: expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J. Clin. Invest. 97:604-612.
29. Gonzalo, J., G. Jia, V. Aguirre, D. Friend, A. Coyle, N. Jenkins, G. Lin, H. Katz, A. Lichtman, N. Copeland, et al. 1996. Mouse eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but it is not restricted to a Th2-type response. Immunity. 4:1-14.
30. Baggiolini, M., and C. Dahinden. 1994. CC chemokines in allergic inflammation. Immunol. Today. 15:127-133.
31. Portoles, P., J. Rojo, A. Golby, M. Bonneville, S. Gromkowski, L. Greenbaum, C.A. Janeway, D.B. Murphy, and K. Bottomly. 1989. Monoclonal antibodies to murine CD3∈ define distinct epitopes, one of which may interact with CD4 during T cell activation. J. Immunol. 142:4169-4175.
32. Chirgwin, J., A. Przybyla, R. MacDonald, and W. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources rich in ribonuclease. Biochemistry. 18:5294-5299.
33. Luster, A., and P. Leder. 1993. IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo. J. Exp. Med. 178:1057-1065.
34. + pulmonary dendritic cells display cell surface antigen heterogeneity. Am. J. Respir. Cell. Mol. Biol. 5:276-283.
35. MacLean, J., Z. Su, R. Colvin, and J. Wong. 1995. Anti-CD3:anti-IL-2 receptor bispecific monoclonal antibody mediated immunomodulation: low systemic toxicity, differential effect on lymphoid tissue, and inhibition of cell-mediated hypersensitivity. J. Immunol. 155:3674-3682.
36. Rothenberg, M., R. Ownbey, P. Mehlhop, P. Loiselle, M. van de Rijn, J. Bonventre, H. Oettgen, P. Leder, and A. Luster. 1996. Eotaxin triggers eosinophil selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin-5 in mice. Molecular Medicine. 2:334-348.
37. Griffiths-Johnson, D., P. Collins, A. Rossi, P. Jose, and T. Williams. 1993. The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo. Biochem. Biophys. Res. Comm. 197:1167-1172.
38. Collins, P.D., S. Marleau, J.D. Griffiths, P.J. Jose, and T.J. Williams. 1995. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J. Exp. Med. 182:1169-1174.
39. Gao, J.-L., A. Sen, L. Tiffany, O. Yoshi, M. Rothenberg, P. Murphy, and A. Luster. 1996. Identification of a mouse eosinophil-selective receptor for the CC chemokine eotaxin. Biochem. Biophys. Res. Commun. 223:679-684.
40. Daugherty, B.L., S.J. Siciliano, J.A. DeMartino, L. Malkowitz, A. Sirotina, and M.S. Springer. 1996. Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J. Exp. Med. 183:2349-2354.
41. Hirsch, H., R.E. Gress, D.H. Pluznik, M. Eckhaus, and J.A. Bluestone. 1989. Effects of in vivo administration of anti-CD3 monoclonal antibody on T cell function in mice. II. In vivo activation of T cells. J. Immunol. 142:737-743.
42. Alegre, M.L., P. Vandenabeele, M. Depierreux, S. Fiorquin, M. Deschodt-Lanckman, V. Flamand, M. Moser, O. Leo, J. Urbain, W. Fiers, and M. Goldman. 1991. Cytokine release syndrome induced by the 145-2C11 anti-CD3 monoclonal antibody in mice: prevention by high doses of methylprednisolone. J. Immunol. 146:1184-1191.
43. Zweiman, B. 1993. The late-phase reaction: role of IgE, its receptor and cytokines. Curr. Opinion Immunol. 5:950-955.